Raras
Buscar doenças, sintomas, genes...
Carcinoma da linha média NUT
ORPHA:443167CID-10 · C80.9DOENÇA RARA

Carcinoma raro, altamente agressivo e letal que afeta crianças e adultos jovens. Surge de estruturas epiteliais da linha média, mais comumente cabeça, pescoço e mediastino. É um carcinoma pouco diferenciado e é caracterizado por mutações e rearranjos do gene NUT. Está presente uma translocação balanceada t(15;19) que resulta na criação de um gene de fusão envolvendo o gene NUT, mais comumente o gene de fusão BRD4-NUT.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Carcinoma raro, altamente agressivo e letal que afeta crianças e adultos jovens. Surge de estruturas epiteliais da linha média, mais comumente cabeça, pescoço e mediastino. É um carcinoma pouco diferenciado e é caracterizado por mutações e rearranjos do gene NUT. Está presente uma translocação balanceada t(15;19) que resulta na criação de um gene de fusão envolvendo o gene NUT, mais comumente o gene de fusão BRD4-NUT.

Publicações científicas
228 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
2.0E-4
Worldwide
Casos conhecidos
310
pacientes catalogados
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C80.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
2 sintomas
🧠
Neurológico
1 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

90%prev.
Neoplasia
Muito frequente (99-80%)
55%prev.
Neuroblastoma
Frequente (79-30%)
55%prev.
Leucemia
Frequente (79-30%)
55%prev.
Morfologia anormal do mediastino
Frequente (79-30%)
55%prev.
Pancreatoblastoma
Frequente (79-30%)
55%prev.
Carcinoma de células escamosas
Frequente (79-30%)
9sintomas
Muito frequente (1)
Frequente (7)
Ocasional (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 9 características clínicas mais associadas, ordenadas por frequência.

NeoplasiaNeoplasm
Muito frequente (99-80%)90%
Neuroblastoma
Frequente (79-30%)55%
LeucemiaLeukemia
Frequente (79-30%)55%
Morfologia anormal do mediastinoAbnormality of the mediastinum
Frequente (79-30%)55%
Pancreatoblastoma
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico228PubMed
Últimos 10 anos171publicações
Pico201724 papers
Linha do tempo
2026Hoje · 2026🧪 2012Primeiro ensaio clínico📈 2017Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

NUTM1NUT family member 1Part of a fusion gene inRestrito
FUNÇÃO

Plays a role in the regulation of proliferation. Regulates TERT expression by modulating SP1 binding to TERT promoter binding sites

LOCALIZAÇÃO

CytoplasmNucleus

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
47.1 TPM
Intestino delgado
0.2 TPM
Cerebelo
0.2 TPM
Cólon transverso
0.1 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
OUTRAS DOENÇAS (1)
nut midline carcinoma
HGNC:29919UniProt:Q86Y26
BRD4Bromodomain-containing protein 4Part of a fusion gene inAltamente restrito
FUNÇÃO

Chromatin reader protein that recognizes and binds acetylated histones and plays a key role in transmission of epigenetic memory across cell divisions and transcription regulation (PubMed:20871596, PubMed:23086925, PubMed:23317504, PubMed:29176719, PubMed:29379197). Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structu

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (2)
Regulation of PD-L1(CD274) transcriptionPotential therapeutics for SARS
MECANISMO DE DOENÇA

Cornelia de Lange syndrome 6

A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. It is characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. CDLS6 inheritance is autosomal dominant.

OUTRAS DOENÇAS (3)
Cornelia de Lange syndrome 6Cornelia de Lange syndromenut midline carcinoma
HGNC:13575UniProt:O60885

Variantes genéticas (ClinVar)

132 variantes patogênicas registradas no ClinVar.

🧬 BRD4: NM_001379291.1(BRD4):c.2211+2T>C ()
🧬 BRD4: NM_001379291.1(BRD4):c.3G>A (p.Met1Ile) ()
🧬 BRD4: NM_001379291.1(BRD4):c.3782+6C>T ()
🧬 BRD4: NM_001379291.1(BRD4):c.3710_3719del (p.Arg1237fs) ()
🧬 BRD4: NM_001379291.1(BRD4):c.555_558del (p.Thr186fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1 variantes classificadas pelo ClinVar.

1
VUS (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
NSD3: NM_023034.2(NSD3):c.3237C>G (p.Asn1079Lys) [Uncertain significance]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 14
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Carcinoma da linha média NUT

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

19 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
174 papers (10 anos)
#1

A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report.

International medical case reports journal2026

NUT (nuclear protein in testis) carcinoma is a rare but aggressive cancer, which was first described in 1991. Given the rarity of this enigmatic entity, risk factors are unknown, treatment options are limited, and the prognosis is dismal. We present the case of a 30-year-old male who presented with acute respiratory failure secondary to a rapidly enlarging mediastinal mass and was subsequently diagnosed with NUT carcinoma. A 30-year-old male presented with symptoms of rapidly progressive shortness of breath and chest pain. CT chest revealed mediastinal lymphadenopathy with extrinsic compression of the left lower lobe bronchus leading to lobar atelectasis. Bronchoscopy with endobronchial ultrasonography was performed to obtain a fine-needle aspirate of the subcarinal lymph node, which was consistent with poorly differentiated carcinoma. An ultrasound-guided percutaneous right supraclavicular core-needle biopsy confirmed NUT carcinoma. Despite prompt initiation of mechanical ventilation as well as chemotherapy, the patient's condition continued to deteriorate and he passed away after being hospitalized for 127 days. Mediastinal NUT carcinoma is a rare cause of acute respiratory failure. Despite the rarity of this cancer, its aggressive and serious nature necessitates all physicians to be aware of this clinical entity and maintain a high index of suspicion. Prompt diagnosis and initiation of chemotherapy is essential. The prognosis remains dismal given that the cancer is resistant to known antineoplastic therapies. Further research should focus on new treatment paradigms for this rare cancer and patients should be encouraged to participate in clinical trials.

#2

International guidelines on the diagnosis and treatment of NUT carcinoma.

Innovation (Cambridge (Mass.))2026 Jan 05

Nuclear protein in testis (NUT) carcinoma (NC) represents a rare, clinically aggressive cancer defined by pathognomonic NUT Midline Carcinoma Family Member 1 (NUTM1) gene fusions, with bromodomain and extraterminal domain (BET) protein 4 (BRD4)-NUTM1 being the predominant oncogenic driver. Since its description in 1991, gradual advances have clarified the pathologic mechanisms of NC and its diagnostic methods; however, NC treatment remains a significant challenge. Moreover, diagnostic and treatment approaches for this cancer require further validation and standardization. These guidelines were developed by the Chinese Alliance of Research for NC (ChARN) based on current evidence in the literature and incorporate consensus-based input from multiple international experts. They provide comprehensive guidance on NC diagnosis and treatment, covering epidemiology, pathogenesis, diagnostic methods, therapeutic strategies, BET-inhibitor toxicity, palliative care, and prognostic assessment during follow-up. They also emphasize the importance of multidisciplinary team collaboration in NC treatment and recommend prioritizing enrollment in prospective clinical trials for patients. Current mainstays of treatment include surgical resection, radiotherapy, and medical treatment (chemotherapy, targeted therapy, and immunotherapy), although no standard treatment protocol exists. Future research directions include improving diagnostic efficiency, exploring new therapeutic strategies (such as highly selective BET inhibitors, BET-inhibitor combinations, and PROTAC technologies), and recommending basket trials as a research approach for patients with NUTM1 gene fusions.

#3

Primary Uterine NUT Carcinoma: A Case Report and Literature Review.

Clinics and practice2026 Jan 21

Background: Nuclear protein in testis (NUT) carcinoma is a rare, aggressive, and poorly differentiated epithelial malignancy characterized by the rearrangement of NUTM1 (NUT midline carcinoma family member 1) on 15q14. It primarily originates along the midline structures, including the head, neck, thorax, and mediastinum. Although NUT carcinoma of the pelvic gynecological organs is exceedingly rare, reported cases have been limited to primary or metastatic ovarian tumors. Here, we present the first documented case of primary uterine NUT carcinoma. Case presentation: A 53-year-old postmenopausal woman presented with abnormal uterine bleeding and a uterine mass. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. The initial postoperative histopathological evaluation suggested undifferentiated endometrial sarcoma; however, subsequent immunohistochemical (IHC) analysis and fluorescence in situ hybridization revealed NUTM1 rearrangement, confirming the diagnosis of NUT carcinoma. The patient experienced tumor recurrence six months postoperatively and succumbed to the disease nine months later. Discussion: The pathological diagnosis was challenging; the presence of abrupt squamous differentiation prompted further IHC analysis, leading to the definitive diagnosis. Primary uterine NUT carcinoma may be misdiagnosed as other undifferentiated uterine tumors due to its rarity and histological overlap. Conclusions: Given the diagnostic challenges, NUT IHC staining and molecular testing for NUTM1 rearrangement should be considered in undifferentiated uterine tumors with ambiguous histopathological features.

#4

An Early-Stage Nuclear Protein in Testis Carcinoma of the Lung in an Older Woman.

Interdisciplinary cardiovascular and thoracic surgery2026 Jan 06

A nuclear protein in testis (NUT) carcinoma is a rare, aggressive malignancy often diagnosed late due to non-specific symptoms and low awareness. A 69-year-old woman presented with haemoptysis and a positron emission tomography-avid lung nodule (cT1N0M0). An initial bronchoscopic biopsy suggested small cell carcinoma with negative NUT staining. Following a lobectomy, immunohistochemical analysis showed strong nuclear NUT positivity, and fluorescence in situ hybridization confirmed NUT rearrangement. This case was atypical due to the patient's age, early stage, and initial misdiagnosis from a limited biopsy. The non-specific presentation of an NUT carcinoma requires a high degree of suspicion, and small biopsies risk a misdiagnosis.

#5

A Case Report of Undifferentiated NUT Carcinoma of Lung Diagnosed by EBUS-FNA: If You Hear Hoofbeats Do Not Assume They Are Horses.

Diagnostic cytopathology2025 Nov 24

NUT carcinoma (NC) is a rare and highly aggressive type of poorly differentiated carcinoma that originates from undefined anatomical sites, primarily in midline structures of the upper respiratory tract. We report the case of a male patient in his fifth decade of life who is a non-smoker. He presented with symptoms of dyspnea and cough, and had previously been treated for an atypical infectious process. A PET scan revealed a right pulmonary hilar mass alongside pathological lymphadenopathy. An endobronchial ultrasound-guided fine needle aspiration (EBUS-FNA) of the subcarinal lymph node was performed, followed by a cytomorphological evaluation in situ (Rapid On-Site Evaluation-ROSE) for sample management. The smear showed high hypercellularity with loosely cohesive cells arranged mostly in a single-cell pattern, exhibiting a poorly differentiated appearance. Immunohistochemical studies on the cell block indicated nuclear positivity for NUT expression, confirming the diagnosis of pulmonary NC. Poorly differentiated high-grade neoplasms in middle-aged patients present a significant challenge when the tumor sample is limited. The cytopathologist's role is to optimize the available material for a complete and accurate diagnosis, which is essential for appropriate treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC127 artigos no totalmostrando 169

2026

A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report.

International medical case reports journal
2026

International guidelines on the diagnosis and treatment of NUT carcinoma.

Innovation (Cambridge (Mass.))
2026

Primary Uterine NUT Carcinoma: A Case Report and Literature Review.

Clinics and practice
2026

An Early-Stage Nuclear Protein in Testis Carcinoma of the Lung in an Older Woman.

Interdisciplinary cardiovascular and thoracic surgery
2025

A Case Report of Undifferentiated NUT Carcinoma of Lung Diagnosed by EBUS-FNA: If You Hear Hoofbeats Do Not Assume They Are Horses.

Diagnostic cytopathology
2025

Nuclear Protein in Testis (NUT) Carcinoma With Nasopharyngeal and Intracranial Involvement: A Case Report.

Cureus
2025

Etoposide and cisplatin in combination with anlotinib for lung NUT carcinoma: a case report.

Frontiers in oncology
2025

Rapid Progression of Primary Pulmonary NUT Midline Carcinoma: A Case Report and Literature Review.

Respirology case reports
2025

Anti-angiogenic therapy as a beacon of hope in the battle against pulmonary NUT midline carcinoma.

Frontiers of medicine
2025

p63-negative thoracic NUT carcinoma - A potential diagnostic pitfall.

Indian journal of pathology &amp; microbiology
2025

68 Ga-FAP-2286 PET/CT Imaging of Nuclear Protein of the Testis Midline Carcinoma in the Lung.

Clinical nuclear medicine
2025

Sinonasal NUT Carcinoma: A Call for Increased Attention to a Vital Clinical Diagnosis.

Indian journal of surgical oncology
2025

Cerebral CIC-NUTM1 rearrangement sarcoma- case report and review of the literature.

Frontiers in oncology
2025

Challenging diagnosis in pulmonary nut carcinoma: A report of two cases with different histopathologic and molecular features and a novel NUTM1::SPECC1 gene fusion.

Histology and histopathology
2025

Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review.

Frontiers in immunology
2025

Comparison of Molecular Testing Methodologies for CIC-Rearranged Sarcomas.

Archives of pathology &amp; laboratory medicine
2025

Acetylation of histone H2B on lysine 120 regulates BRD4 binding to intergenic enhancers.

bioRxiv : the preprint server for biology
2024

Adverse effects of electronic cigarettes on human health.

Journal of dental sciences
2024

Primary thyroid nuclear protein in testis carcinoma: a case report and literature review.

Gland surgery
2024

Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
2024

CIC::NUTM1 sarcomas occurred in soft tissues of upper limbs : a rare case report and literature review.

Diagnostic pathology
2024

Immunotherapy experience in sinonasal NUT midline carcinoma, case report.

Journal of cancer research and therapeutics
2024

Metabolic and Epigenetic Reprogramming in a Case of Nuclear Protein in Testis (NUT) Carcinoma of the Retroperitoneum.

Cureus
2024

A Rare Case of P63-Negative Sinonasal Nut Midline Carcinoma in the Elderly.

European journal of case reports in internal medicine
2024

Therapeutic approaches to sinonasal NUT carcinoma: a systematic review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2024

Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.

ACS chemical biology
2023

Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis.

Frontiers in oncology
2023

[Pulmonary nuclear protein of the testis midline carcinoma:a case report].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2023

[Clinicopathological analysis of nuclear protein in testis midline carcinoma].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2023

Diagnostic algorithm for challenging blue cell sinonasal carcinoma.

Pathology, research and practice
2023

Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.

Journal of cancer research and therapeutics
2023

A sinonasal NUT midline carcinoma in an 84-year-old man undergoing radiation and proton therapy.

Clinical case reports
2023

Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.

The oncologist
2023

The expanding universe of NUTM1 fusions in pediatric cancer.

Clinical and translational science
2023

[Radiologic Manifestations of Pulmonary Nuclear Protein in Testis Midline Carcinoma: A Case Report].

Journal of the Korean Society of Radiology
2023

Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation.

Diagnostic cytopathology
2022

Multimodality imaging and treatment of paranasal sinuses nuclear protein in testis carcinoma: A case report.

World journal of clinical cases
2022

NUT Carcinoma-An Underdiagnosed Malignancy.

Frontiers in oncology
2022

NUT Midline Carcinoma: A Rare Solid Tumour Characterized by Chromosome Rearrangement.

Evidence-based complementary and alternative medicine : eCAM
2022

NUT Is a Driver of p300-Mediated Histone Hyperacetylation: From Spermatogenesis to Cancer.

Cancers
2022

Combined Neuroendocrine and Squamous Cell Carcinoma of the Sinonasal Tract: A Morphologic and Immunohistochemical Analysis and Review of Literature.

Head and neck pathology
2022

NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.

Frontiers in oncology
2022

Nuclear protein of the testis midline carcinoma of the thorax.

Japanese journal of clinical oncology
2022

NUT carcinoma of the thorax in a 7-year-old child.

Radiology case reports
2022

NUT midline lung cancer: a rare case report with literature review.

AME case reports
2022

NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report.

Diagnostic pathology
2022

NUT Carcinoma of the Submandibular Gland: A Case at This Uncommon Site with Review of the Literature.

Head and neck pathology
2022

Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus-a case report.

Acta neurochirurgica
2021

Case Report and Literature Review: Primary Pulmonary NUT-Midline Carcinoma.

Frontiers in oncology
2021

Diagnosis of NUT Carcinoma Despite False-Negative Next-Generation Sequencing Results: A Case Report and Literature Review.

OncoTargets and therapy
2021

[NUT-Midline-Carcinoma in patients of advanced age - a rare differential diagnosis].

Laryngo- rhino- otologie
2021

Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.

Cancer medicine
2021

miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.

Cancer research
2021

Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors.

Translational oncology
2021

Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.

Journal of computer assisted tomography
2022

Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.

The American journal of surgical pathology
2021

Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital.

BMC cancer
2021

Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.

Lung cancer (Amsterdam, Netherlands)
2021

Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.

Internal medicine (Tokyo, Japan)
2021

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects.

Oncology letters
2021

NUT Midline Carcinoma of the Lung: Computed Tomography Findings in 10 Patients.

Journal of computer assisted tomography
2021

[A Case Report of Primary Pulmonary NUT Carcinoma and Literature Review].

Zhongguo fei ai za zhi = Chinese journal of lung cancer
2021

Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Virchows Archiv : an international journal of pathology
2020

The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report.

AME case reports
2020

NUT midline carcinoma in a young pregnant female: a case report.

World journal of surgical oncology
2020

Nuclear protein in testis midline carcinoma in a Turkish boy: a case report.

Asian biomedicine : research, reviews and news
2021

NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.

Head and neck pathology
2020

Imaging spectrum of NUT carcinomas.

Clinical imaging
2020

Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.

Orphanet journal of rare diseases
2021

NUT midline carcinomas and their differentials by a single molecular profiling method: a new promising diagnostic strategy illustrated by a case report.

Virchows Archiv : an international journal of pathology
2021

Metastatic NUT Midline Carcinoma Treated With Aggressive Neoadjuvant Chemotherapy, Radiation, and Resection: A Case Report and Review of the Literature.

Journal of pediatric hematology/oncology
2020

A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction.

Annals of hematology
2020

YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.

Head and neck pathology
2020

Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.

Molecular cancer therapeutics
2020

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.

Oncogene
2020

An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.

JNCI cancer spectrum
2020

How Much Can We Bet on Activity of BET Inhibitors Beyond NUT-Midline Carcinoma?

JNCI cancer spectrum
2020

Clinical management of emerging sinonasal malignancies.

Head &amp; neck
2020

Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva.

BioMed research international
2021

Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.

Head and neck pathology
2020

Sinonasal NUT midline carcinoma: A new histological entity.

Indian journal of pathology &amp; microbiology
2020

Successful treatment of a case with NUT midline carcinoma in the larynx and review of the literature.

Clinical case reports
2020

HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.

Head and neck pathology
2020

[Lung Cancer with Prominent Mediastinal Lymphadenopathy - Who Thinks of NUT Carcinoma?].

Pneumologie (Stuttgart, Germany)
2020

Orbital involvement by NUT midline carcinoma: new presentation and encouraging outcome managed by radiotherapy combined with tyrosine kinase inhibitor: a case report.

Diagnostic pathology
2020

[Nuclear protein in testis (NUT) midline carcinoma].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
2020

SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.

Head &amp; neck
2019

NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity.

Critical reviews in oncology/hematology
2019

The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.

Journal of medical case reports
2020

Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma.

Applied immunohistochemistry &amp; molecular morphology : AIMM
2019

NUT midline carcinoma of the head and neck: current perspectives.

OncoTargets and therapy
2019

NUT midline carcinoma in the right orbit: a case report.

Cancer biology &amp; therapy
2019

Nuclear protein of the testis midline carcinoma in the oral cavity: retrospective review of those initially diagnosed as poorly differentiated squamous cell carcinoma using an anti-C52B1 antibody.

International journal of oral and maxillofacial surgery
2019

A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature.

Journal of medical case reports
2019

High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.

Archives of pathology &amp; laboratory medicine
2019

Midline carcinoma expressing NUT in malignant effusion cytology.

Diagnostic cytopathology
2019

NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2018

NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report.

BMC cancer
2018

NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.

Pathology international
2018

Nut Directs p300-Dependent, Genome-Wide H4 Hyperacetylation in Male Germ Cells.

Cell reports
2018

Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is.

Genes &amp; development
2018

Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation.

Journal of pathology and translational medicine
2018

NUT midline carcinoma with leukemic presentation mimicking CD34-positive acute leukemia.

Blood
2018

Rediagnosis of Lung Cancer as NUT Midline Carcinoma Based on Clues From Tumor Genomic Profiling.

Journal of the National Comprehensive Cancer Network : JNCCN
2018

NUT Midline Carcinoma in the Mediastinum in a Ten-Year-Old Boy.

Archivos de bronconeumologia
2018

miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein.

Scientific reports
2018

[Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].

Der Pathologe
2018

Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2018

NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.

The American journal of surgical pathology
2017

Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease.

Oncotarget
2018

Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study.

Neoplasma
2017

NUT midline carcinoma as a primary lung tumor: a case report.

Journal of thoracic disease
2017

A 48-Year-Old Male with Cutaneous Metastases of NUT Midline Carcinoma Misdiagnosed as Herpes Zoster.

Case reports in oncology
2017

NUT Midline Carcinoma of the Lung in a Six-Year-Old Child.

Fetal and pediatric pathology
2017

Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.

Pediatric hematology and oncology
2017

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Tumori
2018

NUT Midline Carcinoma: A Series of Five Cases, Including One with Unusual Clinical Course.

Head and neck pathology
2017

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Cell reports
2018

NUT midline carcinoma causing critical stenosis of the coronary arteries: CT demonstration.

Surgery
2017

Deciphering the Role of microRNAs in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma.

Bioinformation
2017

Nuclear Protein in Testis Midline Carcinoma Presenting in an Infant as a Pericardial Mass with Staging by 18F-Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography.

World journal of nuclear medicine
2017

NUT carcinoma in children and adults: A multicenter retrospective study.

Pediatric blood &amp; cancer
2017

Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.

Proceedings of the National Academy of Sciences of the United States of America
2017

Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.

Molecular cell
2017

Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.

Proceedings of the National Academy of Sciences of the United States of America
2017

NUT Midline Carcinoma: A Rare Malignancy.

Cancer control : journal of the Moffitt Cancer Center
2017

Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.

Annals of oncology : official journal of the European Society for Medical Oncology
2017

Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.

BMC cancer
2017

NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Head and neck pathology
2017

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology
2017

SMARCA4-deficient Sinonasal Carcinoma.

Head and neck pathology
2017

Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers.

Molecular cancer therapeutics
2017

NUT midline carcinoma of the larynx: an international series and review of the literature.

Histopathology
2017

Cytopathologic and immunophenotypic changes in NUT midline carcinoma after targeted therapy.

Cancer cytopathology
2016

NUT midline carcinoma mimicking a germ cell tumor: a case report.

BMC cancer
2017

NUT Midline Carcinoma of the Nasal Cavity.

Head and neck pathology
2016

The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns.

PloS one
2017

INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.

Head and neck pathology
2016

Nuclear protein in testis (NUT) midline carcinoma with a novel three-way translocation (4;15;19)(q13;q14;p13.1).

Pathology
2016

Poorly differentiated sinonasal tract malignancies: A review focusing on recently described entities.

Ceskoslovenska patologie
2016

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Cancer
2016

Small-Molecule Targeting of BET Proteins in Cancer.

Advances in cancer research
2016

Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.

Cancer cytopathology
2016

Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature.

Diagnostic cytopathology
2016

Targeting BET bromodomain proteins in solid tumors.

Oncotarget
2016

NUT midline carcinoma of the lung, a rare form of lung cancer.

Archivos de bronconeumologia
2016

Nuclear protein in testis midline carcinoma of larynx: An underdiagnosed entity.

Head &amp; neck
2016

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.

Cancer discovery
2015

[NUT midline carcinoma of sinonasal tract: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2016

Newly Described Tumor Entities in Sinonasal Tract Pathology.

Head and neck pathology
2016

Recently described neoplasms of the sinonasal tract.

Seminars in diagnostic pathology
2016

Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations.

Pediatric cardiology
2015

NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates.

Annals of clinical and laboratory science
2016

Sinonasal small round blue cell tumors: An approach to diagnosis.

Seminars in diagnostic pathology
2015

A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma.

Oncogenesis
2015

Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature.

Expert review of anticancer therapy
2016

The Gross Appearance of a NUT Midline Carcinoma.

International journal of surgical pathology
2015

Sinonasal NUT-Midline Carcinoma - A Multimodality Approach to Diagnosis, Staging and Post-Surgical Restaging.

Cureus
2015

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.

Genes &amp; development
2015

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

The American journal of case reports
2015

Cytologic findings of NUT midline carcinoma in the hilum of the lung.

Diagnostic cytopathology
2016

First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.

Journal of chemotherapy (Florence, Italy)
2015

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2015

NUT Midline Carcinoma in Elderly Patients: Usefulness of 18F-FDG PET/CT for Treatment Assessment.

Clinical nuclear medicine
2015

A case of endobronchial NUT midline carcinoma with intraluminal growth.

Anticancer research
2015

Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review.

Case reports in pathology
2015

NUT midline carcinoma presenting with bilateral ovarian metastases: a case report.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
2015

Histone deacetylase inhibitor for NUT midline carcinoma.

Pediatric blood &amp; cancer
2015

NUT protein immunoreactivity in ovarian germ cell tumours.

Pathology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Carcinoma da linha média NUT.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Carcinoma da linha média NUT

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report.
    International medical case reports journal· 2026· PMID 41800272mais citado
  2. International guidelines on the diagnosis and treatment of NUT carcinoma.
    Innovation (Cambridge (Mass.))· 2026· PMID 41737331mais citado
  3. Primary Uterine NUT Carcinoma: A Case Report and Literature Review.
    Clinics and practice· 2026· PMID 41590214mais citado
  4. An Early-Stage Nuclear Protein in Testis Carcinoma of the Lung in an Older Woman.
    Interdisciplinary cardiovascular and thoracic surgery· 2026· PMID 41339294mais citado
  5. A Case Report of Undifferentiated NUT Carcinoma of Lung Diagnosed by EBUS-FNA: If You Hear Hoofbeats Do Not Assume They Are Horses.
    Diagnostic cytopathology· 2025· PMID 41277582mais citado
  6. Downhill Esophageal Variceal Rupture Caused by Superior Vena Cava Syndrome in NUT Carcinoma: A Case Report.
    Cureus· 2026· PMID 41988352recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:443167(Orphanet)
  2. MONDO:0005563(MONDO)
  3. GARD:21852(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q6955667(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Carcinoma da linha média NUT
Compêndio · Raras BR

Carcinoma da linha média NUT

ORPHA:443167 · MONDO:0005563
Prevalência
<1 / 1 000 000
Casos
310 casos conhecidos
Herança
Not applicable
CID-10
C80.9 · Neoplasia maligna, sem especificação de localização
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
2.0E-4 (Worldwide)
MedGen
UMLS
C1707291
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades